Study shows nasal immunization against SARS-CoV-2 inhibit contamination in mice Kumar Jeetendra | August 23, 2020 Researchers have built up an immunization that objectives the SARS-CoV-2 infection, can be given in one portion by means of the nose and is compelling in forestalling disease in mice powerless to the novel corona virus. The examiners next arrangement to test the immunization in nonhuman primates and people to check whether it is sheltered …
Moderna finishes up cutting edge chats with EU for COVID-19 immunization gracefully Kumar Jeetendra | August 24, 2020 Moderna Inc said on Monday it’s concluded advanced exploratory talks with the European Commission to supply 80 million doses of its COVID-19 vaccine candidate. The potential arrangement provides for an option for member states to get an additional 80 million doses for a total of around 160 million doses, the business said.
WHO says plasma treatment still ‘trial’ Kumar Jeetendra | August 24, 2020 The World Health Organisation says using plasma by the recovered to treat COVID-19 is still considered an”experimental” therapy and that the preliminary results demonstrating it may function are still”inconclusive.” President Donald Trump on Sunday accepted an emergency authorisation of convalescent plasma for COVID-19 patients. WHO’s chief scientist Dr Soumya Swaminathan said convalescent plasma therapy was …
WHO says 172 nations drawing in with worldwide COVID-19 immunization plan Kumar Jeetendra | August 24, 2020 Many 172 countries are participating with the WHO-led COVAX plan designed to ensure equitable access to COVID-19 vaccines, the World Health Organization said on Monday, but more funding is desperately needed and countries should now make binding commitments. “Initially, when there will be limited distribution (of COVID-19 vaccines), it is important to offer the vaccine …
Blood Pressure may improve COVID-19 endurance rates, study says Kumar Jeetendra | August 24, 2020 Medicine for high blood pressure might improve COVID-19 survival rates, and reduce the seriousness of novel coronavirus disease, especially in patients with hypertension, according to a study. Researchers from the University of East Anglia (UEA) in the UK analyzed 28,000 patients taking antihypertensives — a category of drugs which are used to treat hypertension or …
AstraZeneca begins preliminary of antibody treatment for COVID-19 Kumar Jeetendra | August 25, 2020 AstraZeneca said on Tuesday it began early stage trials to get an antibody-based treatment for the prevention and treatment of COVID-19, as the British drugmaker also ploughs on with its vaccine candidate. The trial will assess if AZD7442, a blend of two monoclonal antibodies, is tolerable and safe in up to 48 healthy participants between …
Coronavirus re-contaminations raise worries about resistance Kumar Jeetendra | August 25, 2020 Two European sufferers are verified to have been re-infected with the coronavirus, raising concerns about people’s immunity to the virus since the world struggles to tame the pandemic. The cases, in Belgium and the Netherlands, follow a report this week by researchers at Hong Kong to a guy there who was re-infected using a different …
Stage 2 human preliminary of Oxford antibody may begin from August 26 in Pune Kumar Jeetendra | August 25, 2020 The trial may start from Wednesday, said a top official of the institute, among the 17 sites selected for the phase two human trials in the nation by Serum Institute of India (SII). “To begin with we’ve identified five volunteers who will undergo COVID-19 and antibodies test. Those whose reports are negative will be shortlisted …
FDC dispatches 2 variations of Favipiravir in India at Rs 55 for each tablet Kumar Jeetendra | August 25, 2020 Drug firm FDC Ltd on Tuesday said it has established two variants of this COVID-19 drug Favipiravir under the brand names PiFLU and Favenza. The Drug Controller General of India (DCGI) had previously approved the use of Favipiravir, an off patent, oral antiviral drug that’s been demonstrated to quicken clinical healing from COVID-19 patients with …
Precise Flow Measurement for the Food & Beverage Sector Kumar Jeetendra | August 25, 2020 Titan Enterprises is a leading supplier of precision flow measurement devices for the food and beverage sector. Flow measurement is widely recognised as a critical tool for food and beverage manufacturers looking to control operations including filling of vessels, measurement of liquid ingredients and controlling cleaning processes. For these and other flow measurement operations, Titan offers …
China manages exploratory COVID-19 antibodies to high-chance gatherings since a month, says official Kumar Jeetendra | August 26, 2020 China has been tackling experimental COVID-19 vaccines to teams facing high infection risks since July, a health official told the state . No vaccine has passed final, large-scale trials to show it is safe and effective enough to protect people from contracting the virus which has led to nearly 800,000 deaths worldwide. The purpose is …
High Quality 8-Position Parallel Reaction Station Kumar Jeetendra | August 26, 2020 Asynt has introduced a second-generation version of its popular DrySyn OCTO reaction station that delivers the same outstanding performance, at the same price, with improved features and a new, more aesthetically pleasing, design. Like its popular predecessor, the DrySyn OCTO Mk II is an 8-position reaction station that provides chemists with powerful magnetic stirring, heating, …
